Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-641


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 340, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
MRPS15 hsa-miR-641 low: 0 high: 1 1 1 1 0.541
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr1:36456289-36456304 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZNHIT6 hsa-miR-641 low: 0 high: 1 1 1 1 0.524
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr1:85653248-85653273 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TMED5 hsa-miR-641 low: 0 high: 1 1 1 1 0.623
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr1:93154382-93154399 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FBXL5 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr4:15612354-15612381 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MED28 hsa-miR-641 low: 0 high: 1 1 1 1 0.623
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr4:17614656-17614682 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TGIF2 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr20:36593885-36593912 PAR-CLIP POSITIVE DIRECT TarBase 7.0
MXI1 hsa-miR-641 low: 0 high: 1 1 1 1 0.739
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr10:110285938-110285966 HITS-CLIP POSITIVE DIRECT TarBase 7.0
HELLS hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr10:94592470-94592494 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PANK3 hsa-miR-641 low: 0 high: 1 1 1 1 0.481
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr5:168550439-168550454 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MRPS14 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:175013548-175013571 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TNFRSF10B hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr8:23028375-23028401 HITS-CLIP POSITIVE DIRECT TarBase 7.0
AKAP1 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr17:57120977-57121001 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TBC1D15 hsa-miR-641 low: 0 high: 1 1 1 1 0.756
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr12:71893265-71893284 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PDS5A hsa-miR-641 low: 0 high: 1 1 1 1 0.707
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr4:39824306-39824332 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CLCC1 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr1:108932322-108932341 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RBBP6 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr16:24540497-24540525 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TUBA1B hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr12:49127842-49127864 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FAM199X hsa-miR-641 low: 0 high: 1 1 1 1 0.842
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chrX:104195122-104195143 HITS-CLIP POSITIVE DIRECT TarBase 7.0
AGO2 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr8:140531202-140531217 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ATP5E hsa-miR-641 low: 0 high: 1 1 1 1 0.474
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr20:59028732-59028744 HITS-CLIP POSITIVE DIRECT TarBase 7.0